“Xenograft”: Japanese study transplants pig islet cells into humans
China News Service, August 7th. According to reports from the Japanese media, recently, a research team at the National Medical Research Center of Japan, Meiji University, Kyoto Prefecture University, and Fukuoka University has started the development of transplanting pancreatic islet cells from pig pancreas to patients with type 1 diabetesBody, as the technology of artificial guide island.
Data map: Pigs According to reports, the Japanese government has in fact vertically restricted xenotransplantation of animal cells and tissues into humans, and relaxed relevant regulations in 2016.
The research team will use the full advancement development of pigs with organs similar to humans.
As a means to improve the shortage of human organs, it is planned to be practical in 3 to 5 years.
It is understood that type 1 diabetes patients account for several complications of diabetes, and Japan 南京夜网 is considered to have 70,000 to 100,000 patients.
Because platelet island cells do not work, they cannot produce insulin that lowers blood sugar levels, and they can only inject insulin.
To completely cure type 1 diabetes requires organ transplantation, but there is a problem of insufficient donors.
The Air Force, some countries have conducted experiments to transplant pig cells.
As related experiments did not appear to be infected with a specific virus, the Japanese Ministry of Health, Labour and Welfare research team relaxed the relevant regulations.
It is reported that Meiji University in Japan has built a sterile pig farm.
Kyoto Prefectural University will develop a detection method to investigate pathogen infection in-house in 2017.
The National Center for International Medical Research is responsible for wrapping piglet’s plasma islands with materials that prevent immunoresection to prevent substitutions in patients.
Expected R & D expenses are 1.
500 million yen, provided by the Japan IDDM Network, a certified NPO corporation (non-profit organization) that supports type 1 diabetes patients and their families across Japan.
It is understood that New Zealand startups have developed artificial islets using pig islets and are conducting clinical trials in Russia, New Zealand and other places.
It is reported that the maximum can continue to have the effect of lowering the target value of blood glucose for about 2 years and reducing the number of incidences due to hypoglycemia.
Original title: “Xenograft”: Japanese study transplants pig islet cells into human body